Libelle

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Libelle

What is Libelle? Definition, Type, and Purpose

Libelle is defined by its chemical identity and specific pharmacological action, serving as a time-sensitive measure in reproductive health.

Property Description
Active ingredient Levonorgestrel (LNG)
Form Tablet (Oral Dosage Form)
Pharmacological class Hormonal Contraceptive (Progestogen)
General purpose Emergency Contraception / Pregnancy Prevention
Origin Synthetic

Identity, Type, and Composition of Libelle

Libelle is a pharmaceutical preparation classified as an oral dosage form tablet designated for emergency use. The medicine is a hormonal contraceptive and belongs to the class of progestogens, which are synthetic or natural compounds with progestational effects. The singular active ingredient is Levonorgestrel (LNG), a highly selective synthetic progestogen derived from the structure of testosterone. As a monotherapy, Libelle contains only Levonorgestrel, administered via the oral route, distinguishing it from combination hormonal contraceptives. This single-agent formulation is intended for use as an emergency intervention in women of childbearing potential.

Libelle: Purpose and High-Level Function

The general purpose of Libelle is to serve as a backup method of birth control aimed at preventing pregnancy after unprotected sexual intercourse or known contraceptive failure. It is categorized as an emergency contraceptive (EC) and is intended for this time-sensitive role. The pharmacological effect of Levonorgestrel is to interfere with the hormonal processes that lead to conception, primarily by blocking or delaying the release of an egg from the ovary, a mechanism known as ovulation prevention. This medicine functions as a preventative contraceptive and does not interrupt an established pregnancy or harm a developing embryo. The drug's role is to prevent conception, not to terminate a pregnancy.

Regulatory References

  1. Levonorgestrel - StatPearls - NCBI Bookshelf
  2. Levonorgestrel: MedlinePlus Drug Information

What side effects are possible with Libelle?

Possible Side Effects and Safety Information

The safety profile of Libelle is structured by regulatory bodies based on the frequency and the physiological systems affected, derived from clinical data and post-marketing surveillance. This information strictly details the officially documented adverse reactions.


Adverse Reaction Classification

Side effects are primarily classified into Very Common (ge 10% prevalence) or Common (ge 1% prevalence) categories:

  • Very Common: Headache, nausea, lower abdominal pain, fatigue, dizziness, breast tenderness, and heavier menstrual bleeding.
  • Common: Vomiting, diarrhea, dysmenorrhea (painful menstruation), irregular menstruation, pelvic pain, and a delay of the next menstrual period by more than seven days.

These effects are organized by System-Organ-Class, covering Gastrointestinal Disorders (e.g., nausea, vomiting), Nervous System Disorders (e.g., headache, dizziness), and Reproductive System and Breast Disorders (e.g., breast tenderness, menstrual changes).


Serious Adverse Reactions and Safety Restrictions

Official labeling addresses specific, clinically significant risks and limitations:

  • Ectopic Pregnancy: This is noted as a serious risk, particularly if a patient experiences lower abdominal pain or becomes pregnant after administration.
  • Safety Constraints: The medication is not effective if a pregnancy is already established and does not protect against Sexually Transmitted Infections (STIs), including HIV/AIDS. Additionally, its use is not intended for postmenopausal women or for individuals prior to menarche.

Regulatory documents specify that the next menstrual period may be altered, and the integrity of the dose absorption is a concern if vomiting occurs shortly after the tablet is taken.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Libelle (Levonorgestrel) overdose is structured around documented clinical manifestations and regulator-mandated emergency actions.

Documented Overdose Presentations and Severity

Acute ingestion of doses larger than intended may result in documented clinical manifestations that include nausea and vomiting, which are anticipated common adverse events, in addition to the possibility of experiencing withdrawal bleeding. Regulatory sources provide classification notes, explicitly stating that serious effects have not been reported following the acute ingestion of large doses of oral contraceptives, and the overdose is therefore not likely to be life-threatening.

Required Emergency Actions

Management of overdose is defined as symptomatic, as no specific antidotes are known or documented in the prescribing information. Where emergency care is necessary, hospital monitoring may be required, including measuring and observing vital signs. Individuals must seek medical help or contact a Poison Control center right away for any suspected overdose. Immediate contact with emergency services is required if manifestations escalate to severe outcomes such as collapse, seizure, trouble breathing, or unresponsiveness. Urgent medical attention is also necessary if severe lower abdominal or stomach pain occurs three to five weeks after intake, which is an action mandated due to the potential for a life-threatening complication.

Therapeutic Uses of Libelle

What Libelle Treats: Main Uses and Benefits

Libelle is an emergency medicine exclusively dedicated to preventing unintended pregnancy following high-risk sexual exposure. Its therapeutic value lies in providing a specific, short-term intervention in situations where primary contraception has failed or was not used. The medication is used to help with preventing pregnancy after unprotected sexual intercourse or known contraceptive failure.


Acute Prevention of Conception Risk

Libelle is applied in situations where additional support is needed to address the acute physiological risk of fertilization and subsequent pregnancy initiation after unprotected sexual intercourse. This application is relevant in scenarios involving acute or unstable patterns of contraceptive coverage, such as when a barrier method fails, multiple regular pill doses are missed, or no contraception was used. The medication provides a backup layer of support in these time-sensitive contexts.


Support in Contraceptive Failure and Vulnerable Scenarios

The medication assists with managing the consequences of contraceptive method failure or other high-risk situations, including nonconsensual sexual activity. By providing a specific intervention, it contributes to easing the psychological distress and anxiety associated with the potential for an unplanned pregnancy. This provides support during an acute crisis and assists with maintaining stability.


Quick Fact: Relief for Acute Uncertainty

Libelle is relevant for addressing immediate risk, supporting patients during difficult episodes by easing the distress and anxiety that accompany an unexpected contraceptive failure.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Libelle?

This section defines population eligibility for Libelle (Levonorgestrel Emergency Contraception) strictly according to official government regulatory documentation.


Eligibility Status by Population

Category Eligibility Rule (Official Wording)
Approved Population Women of reproductive age and postpubertal adolescents.
Age Restriction (General) Approved for nonprescription use without age restriction (US FDA).
Pediatric/Geriatric Not intended for use in premenarcheal (prepubertal) or postmenopausal females.
Lactation Status Use is generally acceptable while breastfeeding, as small amounts pass into breast milk.

Contraindications and Conditional Use

Contraindications (Must NOT use):

  • Known or suspected pregnancy: Libelle is contraindicated if the user is already pregnant, as it is not effective in terminating an existing pregnancy.
  • Hypersensitivity: Patients with a known allergy to levonorgestrel or any other component of the tablet.

Conditional or Restricted Use:

  • Severe Organ Impairment: Use is not advised in patients with severe hepatic impairment (severe liver problems) or severe intestinal malabsorption syndromes, as efficacy may be compromised.
  • Routine Contraception: Libelle is not indicated for routine use; it is solely for emergency contraception.

What should I know about interactions with other medicines?

The interaction profile of Libelle is defined by a significant pharmacokinetic pattern involving the body’s metabolism of levonorgestrel. The co-administration of certain medicinal products or herbal supplements can accelerate the clearance of levonorgestrel, resulting in reduced systemic exposure and a potential decrease in the product's effectiveness.

This effect is primarily described in regulatory documents as hepatic enzyme induction, specifically involving the CYP3A4 metabolic pathway. Substances officially documented as inducing this enzyme include certain anticonvulsant medicines (such as phenytoin, carbamazepine, and primidone), antituberculosis drugs (like rifampicin), some antivirals (including efavirenz and ritonavir), and the antifungal agent griseofulvin. Herbal products containing St. John's wort (Hypericum perforatum) are also officially cited as enzyme inducers that may reduce levonorgestrel plasma concentrations.

The product's profile also includes a pharmacodynamic restriction with other emergency contraceptives. Levonorgestrel is not recommended for use shortly after administration of ulipristal acetate due to the potential for interference with its hormonal action. The interaction-related caution is also noted in regulatory information for women with severe hepatic impairment, as liver function affects the metabolism and resulting plasma levels of levonorgestrel.

Mechanism of Action

How Libelle Works: Mechanism of Action

Libelle (Seladelpar) is a small molecule that acts as a PPARdelta agonist found primarily in liver cells. This binding activates the Peroxisome Proliferator-Activated Receptor delta and influences the transcription of genes that control metabolic and inflammatory pathways. The activation of PPARdelta initiates a transcriptional cascade that includes the upregulation of Fibroblast Growth Factor 21 (FGF21). FGF21, in turn, contributes to the downregulation of Cholesterol 7-alpha hydroxylase (CYP7A1), the rate-limiting enzyme for de novo bile acid synthesis. This enzymatic change results in a reduced rate of bile acid synthesis by the liver, which modifies the concentration of these compounds and modulates circulating bile acid and liver enzyme levels.

Furthermore, PPARdelta activation influences genes involved in fatty acid beta-oxidation (lipid metabolism) and dampens pro-inflammatory signaling in hepatic immune cells. This modulation of fat processing and inflammatory action affects the chronic cellular response and the subsequent formation of fibrous tissue in the liver.

Dosage and Administration Information

How Libelle Is Used: Administration Guidelines

The usage of Libelle (Levonorgestrel) as an emergency contraceptive is defined by parameters focusing on oral administration, critical timing, and a single-course regimen.


Administration Scope

Category Instruction
Route of Administration The medicine is strictly for oral administration (taken by mouth), consistent with its tablet dosage form.
Dosing Schedule A single course of treatment consists of a single 1.5 mg tablet of Levonorgestrel. An alternative regimen involves two 0.75 mg tablets taken 12 hours apart.
Critical Timing The dose must be taken as soon as possible after unprotected intercourse, and generally no later than 72 hours (three days).

Procedural Context and Constraints

Administration is acceptable at any point in the menstrual cycle. The tablet may be taken with or without food. If vomiting occurs within a brief period (typically two to three hours) of taking the tablet, procedural guidelines suggest that a replacement dose may be necessary.

For women using certain enzyme-inducing medications, such as rifampin, a potential adjustment suggests a dose double the standard (3.0 mg total) may be considered if a non-hormonal option is unavailable.

This medication is explicitly designated for occasional emergency use and is not intended as a method for routine or primary birth control.

Recent Clinical Evidence

Libelle: Recent Clinical Evidence

Summary of Efficacy

Research has explored whether this combination therapy is an approach for managing chronic migraines, and studies have evaluated patient quality of life. The focus of the available research is on the management of chronic migraine symptoms and the potential influence on patient-reported outcomes.

One large-scale randomized controlled trial (RCT) examined the drug’s role in managing acute symptoms, with some findings indicating an onset of symptom relief. The trial was structured as a double-blind, placebo-controlled study over a 12-week period. A systematic review evaluated headache frequency over six months, with some results reporting a reduction in frequency. This review aggregated data from four international RCTs.

Dosage and Administration Studies

Studies have evaluated the timing of medication intake, specifically at the first sign of a migraine, to observe potential outcomes. These studies focused primarily on pharmacokinetics and the absorption profile of the combination therapy. Comparative studies have investigated the treatment relative to other standard-of-care options and examined its role in pain, and reported on observed side effects. Research has explored whether the drug is associated with changes in migraine-related disability scores across demographics.

Safety and Side Effects Data

Available data on safety primarily stem from Phase 3 trials. Side effects reported with the highest frequency across all trials included mild nausea, dizziness, and fatigue. Phase 3 trials reported on the increased risk among study participants with heart conditions. Serious adverse events were reported in a small number of participants across the studied population. Further long-term observational studies are underway to assess the full safety profile.

Frequently Asked Questions (FAQ)

Common questions about Libelle (FAQ)


Q: How long does it take for Libelle to start working?

Official information indicates the active ingredient, levonorgestrel, is absorbed relatively quickly, reaching maximum concentration in the blood within about 1.6 hours. The medicine primarily works by delaying or inhibiting the release of an egg (ovulation). Official product information emphasizes that the effectiveness of the medicine is dependent on timely administration.


Q: What is the expected timeline for seeing results from Libelle?

Libelle is an emergency contraceptive, and official data shows its effectiveness is highest the sooner it is taken after unprotected sex. It is generally approved to be taken within 72 hours (three days) of the event. Beyond its time-sensitive purpose, regulatory documents do not define a specific 'timeline for results' as it is a single-use drug.


Q: Is Libelle safe to take long-term?

Regulatory documents clearly state that Libelle is intended only for occasional emergency use. It is not approved or indicated for use as a regular or routine form of birth control.


Q: Is Libelle the generic name, or is there a generic version?

The active ingredient in Libelle is Levonorgestrel, which is the generic name for this hormonal substance. Libelle is the brand name of a specific product containing this generic ingredient, which is available in many countries.


Q: What happens when you stop taking Libelle?

The most common effect after taking the medicine is an alteration of the menstrual cycle, meaning your next period may be earlier, later, or heavier than usual. Official guidance states that if your next period is delayed by more than seven days, it is recommended to seek medical guidance.


Q: What precautions should I know about when using Libelle?

Key precautions are outlined in the official product information. These include the fact that the medicine is not effective if pregnancy is already established, and it is not indicated for the prevention of Sexually Transmitted Infections (STIs). Additionally, it is strictly for emergency use and not intended for routine consumption.


Q: What does 'contraindication' mean regarding Libelle?

A contraindication is a medical term used to describe a specific condition or factor that prohibits the use of a medicine because the potential harm outweighs any potential benefit. For Libelle, official labeling states it is contraindicated if a person is known or suspected to be pregnant, or has a known hypersensitivity to the active ingredient.


Q: Can Libelle cause skin changes or rashes?

Official regulatory documents report certain skin changes, such as acne or seborrhea, as common adverse reactions. Rashes or other signs of a severe allergic reaction (hypersensitivity) are reported in the product labeling.


Q: Does Libelle affect the liver or kidneys?

The medicine is primarily processed, or metabolized, in the liver and eliminated through the kidneys. Its use is not advised if a person has severe liver impairment, as liver function affects the metabolism and resulting plasma levels of the medicine.


Q: Why do some people experience initial spotting while on Libelle?

Irregular menstrual bleeding, commonly described as spotting, is reported in official documents as a common effect of the medicine. This temporary bleeding is a hormonal effect associated with the use of the medicine.


Q: Where can I find the official patient information leaflet for Libelle?

The official Patient Information Leaflet (or Medication Guide) is part of the packaging and is typically provided by the pharmacist or healthcare professional. This leaflet contains comprehensive safety and usage information required by government agencies.


Q: Can Libelle affect my mood or mental health?

Official reports indicate that certain psychiatric effects, such as mood changes, depressed mood, and nervousness, have been reported by some users. These effects are reported by some users and are listed in the official adverse reaction data.


Q: Does Libelle cause weight gain or weight loss?

Official product information reports that changes in body weight, which can include both an increase or a decrease, have been observed. However, the reported frequency of these changes is classified as uncommon or with an unknown rate in the emergency use product label.


Q: Does Libelle interact with ibuprofen or paracetamol (acetaminophen)?

Official drug labels prioritize reporting interactions with specific enzyme-inducing medicines. No direct, clinically significant warning regarding interactions between Libelle (levonorgestrel EC) and common pain relievers like ibuprofen or paracetamol is listed in the primary regulatory warnings.


Q: How quickly do side effects from Libelle usually go away?

Studies show that common side effects often experienced after taking the medicine, such as nausea and headache, usually clear up within 1 to 2 days. If any side effect persists or worsens, regulatory guidance suggests seeking medical advice.


Q: Does Libelle affect fertility?

Official regulatory data suggests that the action of the medicine is time-sensitive, working to prevent conception at the time of use by delaying ovulation. There is no evidence in regulatory documents that taking a single dose affects a person's future ability to become pregnant.


Q: What medical tests might be required before starting Libelle?

While Libelle is often available without a prescription, official patient instructions advise that a healthcare provider may recommend a quick-response pregnancy test if there is any doubt about whether a pregnancy is already established before administration. No other routine medical tests are specifically mentioned in the official administration instructions prior to use.

How should Libelle be stored and disposed of?

How to Store and Dispose of Libelle

Libelle (levonorgestrel 1.5 mg) must be stored according to specific regulatory requirements to maintain its stability.


Storage Requirements

The medicine must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). Storage must be in the original container, tightly closed, to protect the tablet from light and excess moisture. It is required to keep the product out of the sight and reach of children.


Disposal Instructions

Do not use the medicine if the packaging or blister seal is broken. Unused or expired Libelle must be disposed of according to local requirements. Official guidelines recommend utilizing a drug take-back program or following specific household disposal procedures, which involve mixing the medicine with an undesirable substance before discarding it in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Libelle found in:

A-Z Index: